The ensemble of molecular and clinical observations demonstrate that KCNQ1 is a target gene and regulator of the Wnt/β-catenin pathway and its repression leads to CRC cell proliferation, EMT, tumorigenesis and poor patient survival. This evidence concerns the gene KCNQ1 and colorectal carcinoma.